Risedronate sodium and Pleurisy - a phase IV clinical study of FDA data


Pleurisy is found among people who take Risedronate sodium, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Risedronate sodium and have Pleurisy. It is created by eHealthMe based on reports of 9,452 people who have side effects when taking Risedronate sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

9,452 people reported to have side effects when taking Risedronate sodium.
Among them, 31 people (0.33%) have Pleurisy.

What is Risedronate sodium?

Risedronate sodium has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 9,528 Risedronate sodium users for its effectiveness, alternative drugs and more.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 1,595 drugs and 1,084 conditions by eHealthMe.

Number of Risedronate sodium and Pleurisy reports submitted per year:

Could Risedronate sodium cause Pleurisy?

Time on Risedronate sodium when people have Pleurisy *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pleurisy when taking Risedronate sodium *:

  • female: 82.76 %
  • male: 17.24 %

Age of people who have Pleurisy when taking Risedronate sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 24 %
  • 60+: 56 %

Common drugs people take besides Risedronate sodium *:

  1. Prednisolone: 12 people, 38.71%
  2. Cymbalta: 12 people, 38.71%
  3. Solu-Medrol: 7 people, 22.58%
  4. Colchicine: 6 people, 19.35%
  5. Mycophenolate Mofetil: 6 people, 19.35%
  6. Methotrexate: 6 people, 19.35%
  7. Zolmitriptan: 6 people, 19.35%
  8. Humira: 6 people, 19.35%
  9. Enbrel: 6 people, 19.35%
  10. Zopiclone: 6 people, 19.35%

Common side effects people have besides Pleurisy *:

  1. Pulmonary Oedema (fluid accumulation in the lungs): 13 people, 41.94%
  2. Nausea (feeling of having an urge to vomit): 13 people, 41.94%
  3. Pleural Effusion (water on the lungs): 10 people, 32.26%
  4. Cough: 9 people, 29.03%
  5. Chest Pain: 9 people, 29.03%
  6. Breathing Difficulty: 9 people, 29.03%
  7. Fatigue (feeling of tiredness): 9 people, 29.03%
  8. Chills (felling of cold): 9 people, 29.03%
  9. Pain: 8 people, 25.81%
  10. Dizziness: 8 people, 25.81%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 48.39%
  2. Cellulitis (infection under the skin): 6 people, 19.35%
  3. Pain: 6 people, 19.35%
  4. Migraine (headache): 6 people, 19.35%
  5. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 6 people, 19.35%
  6. Urinary Tract Infection: 6 people, 19.35%
  7. Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 19.35%
  8. High Blood Cholesterol: 6 people, 19.35%
  9. Interstitial Lung Disease: 5 people, 16.13%
  10. Disease Complication: 4 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Risedronate sodium and have Pleurisy?

Check whether Pleurisy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Pleurisy and when was it recovered:

Expand to all the drugs that have ingredients of risedronate sodium:

Alternative drugs to, pros and cons of Risedronate sodium:

Common Risedronate sodium side effects:

Browse all side effects of Risedronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pleurisy treatments and more:

COVID vaccines that are related to Pleurisy:

Common drugs associated with Pleurisy:

All the drugs that are associated with Pleurisy:

Common conditions associated with Pleurisy:

All the conditions that are associated with Pleurisy:

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Risedronate sodium) and Risedronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: